Three Cases of Arterial Occlusion That Occurred After the Use of Angioseal(R).
10.4070/kcj.2008.38.6.339
- Author:
Yun Ho CHOI
1
;
June NAMGUNG
;
Hyunmin CHOE
;
Sung Uk KWON
;
Joon Hyung DOH
;
Sung Yun LEE
;
Chang Young KIM
;
Woo Ik CHANG
;
Won Ro LEE
Author Information
1. Department of Internal Medicine, Vision 21 Cardiac and Vascular Center, College of Medicine, Inje University, Ilsan Paik Hospital, Goyang, Korea. medngj@ilsanpaik.ac.kr
- Publication Type:Case Report
- Keywords:
Percutaneous coronary angioplasty;
Femoral artery;
Closure device
- MeSH:
Femoral Artery;
Glycosaminoglycans;
Humans;
Length of Stay;
Phenobarbital;
Thrombin;
United States Food and Drug Administration;
Walking
- From:Korean Circulation Journal
2008;38(6):339-342
- CountryRepublic of Korea
- Language:English
-
Abstract:
Femoral arterial closure devices are now commonly used after both diagnostic and therapeutic coronary procedures. They have been shown to reduce the time to ambulation and to decrease the length of the hospital stay. Angioseal is a commercially available femoral artery closure device that has been approved by the Food and Drug Administration (FDA). The device sandwiches an intra-arterial absorbable anchor on the luminal side of the vessel and a thrombin plug on the surface of the vessel with using a self-cinching stitch. We report here on three patients who presented with acute and delayed arterial occlusive complications that were found to be due to an Angioseal anchor that was not appropriately reabsorbed.
